An investigation for investors in (NYSE:PHG) shares over possible violations of securities laws by Koninklijke Philips NV was announced and NYSE:PHG stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 10/30/2017 -- An investigation was announced investors in NYSE:PHG shares over potential securities laws violations by Koninklijke Philips NV.
Investors who purchased shares of Koninklijke Philips NV (ADR) (NYSE:PHG) should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The investigation by a law firm focuses on whether a series of statements by Koninklijke Philips NV regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On October 11, 2017, the Company announced that it reached an agreement with the U.S. Department of Justice to temporarily suspend the manufacture and distribution of certain defibrillators for the U.S. market to allow closer inspections and ensure it is in compliance with applicable U.S. Food & Drug Administration regulations.
Those who purchased shares of Koninklijke Philips NV (ADR) (NYSE:PHG) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego